Study reveals promising results for abatacept for severe COVID By iopac on April 26, 2024 Optimal dosing of the drug based on body weight is still unknown. Published in COVID-19 iopac More from COVID-19More posts in COVID-19 »Long-COVID symptoms in kids appear to differ by ageStudy: HHS’s COVID vaccine campaign saved $732 billion in averted infections, costsUS respiratory virus activity tails off to low levelsGAO report shows Strategic National Stockpile challenges during COVID, mpox